ABHI LEADERSHIP
Advancing Healthcare Through the Power of Genomics
The United Kingdom’s leadership in genomics is recognised globally, from the completion of the 100,000 Genomes Project to COVID-19 surveillance through genomic sequencing. Genome UK, which is the UK Government’s 10-year strategy for genomics, sets out an ambition for the UK to be the world’s most advanced genomic healthcare ecosystem. This presents opportunities to accelerate research, develop innovations in new technologies, and apply genomics in the clinical setting to diagnose diseases at an earlier stage, improve therapies, and predict and prevent diseases before they might appear.
Increased Accessibility in Healthcare This is a hugely exciting prospect and strongly aligned with ABHI’s vision to make health technologies accessible to all who need them when they are needed, allowing disease to be detected and treated earlier. In cancer care, harnessing the power of genomics is enabling a shift to personalised medicine through better diagnosis, determining responses to therapies, and raising outcomes by identifying treatments targeted to specific cancer types. Scientific and clinical research is making use of large troves of data and advances in bioinformatics,
Nishan Sunthares Managing Director, Diagnostics, ABHI
data science, and analytics to understand more about the human body and the progression of major diseases. This is used to develop new diagnostics and therapeutics and to bring those benefits back into health care.
A Revolutionary Benefit to Various Sectors The UK is in a fantastic position to lead this revolution in science, technology, and healthcare delivery. Shared standards for collecting, storing, and sharing genomic data across the entire UK genomics ecosystem to build and maintain trust in genomic healthcare are key enablers to delivering the ambition of the Genome UK strategy. These are strong foundations for a thriving industrial sector in the UK, and subsequently, to scale across the globe. As the UK’s trade association for the HealthTech sector, many of our members are already leading the field in this area, and the signs suggest that we are only beginning to scratch the surface as to what is possible. The genomics revolution is coming, and the UK is a genuine world leader.
To find out more about ABHI’s work, visit
www.abhi.org.uk
34 UKHEALTHCARE P A VILION. COM
DUB AI 2023
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58
